Lumetry Diagnostics, based in Vienna, Austria, develops advanced medical devices combining spectroscopy and bio-imaging to monitor lung function non-invasively.
Designed for patients with COPD, asthma, or pneumonia, their capnometer and AI-powered platform enable daily, at-home assessment of lung health via smartphone-connected devices. By measuring CO₂ retention and respiratory markers in real-time, Lumetry eliminates the need for invasive blood tests and supports early intervention, reducing hospital admissions.
Backed by EU research grants and lung-clinic collaborations, their first consumer product is slated for release by end of 2025.
